High quality raw material for IVD manufacturing industry

Recombinant antigen EBNA1 for Epstein-barr virus

RekomBiotech
Epstein-barr virus

EBNA1 has a predominant role in the maintenance of latent EBV infections and is expressed in all EBV infections and all EBV-associated malignant tissues. It contains a Gly-Ala repeated domain flanked by two unique regions. The central , C-terminus and N-terminus regions have been described as potentially antigenic.

View more information about Epstein-Barr virus infection.

REFERENCES
RAG0007 WB, DB, Indirect ELISA, positive control in direct ELISA, CLIA, lateral-flow
RAG0047 WB, DB, Indirect ELISA, positive control in direct ELISA
GENE
BKRF1
DESCRIPTION
Late nuclear antigen
PURITY
>95% in a SDS-PAGE
SHIPPING AND STORAGE CONDITIONS
Proteins will be shipped with dry ice or lyophilized. Upon arrival (if liquid), or after reconstitution (if lyophilized), they should be stored at -20ºC to -80ºC. Avoid multiple freeze/thaw cycles
STABILITY
The protein will remain stable for four years if stored frozen
SPECIFICITY
The protein is immunoreactive against seropositive individuals to Epstein-Barr virus infection
IVD
Serodiagnosis of infectious mononucleosis associated to EBV and primary acute infections in immunocompromised individuals
SATISFACTION GUARANTEE
83% success rate in evaluations of recombinant antigen EBNA1 (RAG0007) for the development of a diagnostic assay
100% success rate in evaluations of recombinant antigen EBNA1 (RAG0047) for the development of a diagnostic assay
RELATED PRODUCTS

FOR RESEARCH ANDCOMERCIAL USE IVD ONLY (*)

(*) Our biomarkers are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. For more information about the general features of our biomarkers, you can visit here.

RETURN TO HUMAN RECOMBINANT ANTIGENS